Stage FocusSeed, Series A
GeographyEurope, US
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedTech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Seroba Life Sciences is a European life sciences VC headquartered in Dublin, with Fund IV closed at €123M in February 2024. The fund targets up to 12 investments per vintage, with 5 already made including Perfuze, Sibylla Biotech, Deciphex, Complement Therapeutics, and Artica. The latest investment is Azafaros' Series B in May 2025, bringing total investments to 50.
The LP base reads like a who's...
Notable Investments
P
PerfuzeS
Sibylla BiotechD
DeciphexC
Complement TherapeuticsA
Artica TherapeuticsA
AzafarosSimilar Funds
Versant Ventures
San Francisco, United States
Pure DeepTechBiotechMedTechSeedSeries A
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedTechSeedSeries A
ARCH Venture Partners
Chicago, United States
Pure DeepTechBiotechMedTechSynthetic BiologySeedSeries A
Atlas Venture
Cambridge, United States
Pure DeepTechBiotechSynthetic BiologyMedTechSeedSeries A
Boehringer Ingelheim Venture Fund
Ingelheim am Rhein, Germany
GeneralistBiotechMedTechPre-SeedSeed
Bold Capital Partners
Santa Monica, United States
Pure DeepTechBiotechAI InfrastructureMedTechSeedSeries A